Moderna leaked data was positive, what's hurting MRNA stock then?

Moderna's (MRNA) leaked cancer-vaccine trial results looked “promising” on the surface, yet the biotech stock came under intense pressure late on Thursday and was weak on Friday morning too, although ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。